PERCEPTIVE ADVISORS LLC Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$3.8T
Holdings
125
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (125 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —AZURRX BIOPHARMA INC | 227,272 | $730.0M | 0.02% | |
| 102 | ARRYEURARRAY BIOPHARMA INC | 40,133 | $673.0M | 0.02% | |
| 103 | —LOXO ONCOLOGY INC | 3,765 | $653.0M | 0.02% | |
| 104 | PTCTPTC THERAPEUTICS INC | 19,367 | $653.0M | 0.02% | |
| 105 | GTHXEURG1 THERAPEUTICS INC | 14,055 | $611.0M | 0.02% | |
| 106 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 49,302 | $585.0M | 0.02% | |
| 107 | COLLCOLLEGIUM PHARMACEUTICAL INC | 24,213 | $577.0M | 0.02% | |
| 108 | VRAYQVIEWRAY INC | 75,000 | $519.0M | 0.01% | |
| 109 | —MOMENTA PHARMACEUTICALS INC | 24,489 | $501.0M | 0.01% | |
| 110 | SENS1GBPSENSEONICS HLDGS INC | 115,000 | $473.0M | 0.01% | |
| 111 | ADVMCHFADVERUM BIOTECHNOLOGIES INC | 80,845 | $428.0M | 0.01% | |
| 112 | —PERNIX THERAPEUTICS HLDGS IN | 1,000,000 | $426.0M | 0.01% | |
| 113 | —VITAL THERAPIES INC | 150,000 | $405.0M | 0.01% | Put |
| 114 | —CASI PHARMACEUTICALS INC | 43,682 | $360.0M | 0.01% | |
| 115 | GBYSANGAMO THERAPEUTICS INC | 25,000 | $355.0M | 0.01% | |
| 116 | VRNAVERONA PHARMA PLC | 22,327 | $307.0M | 0.01% | |
| 117 | HCMHUTCHISON CHINA MEDITECH LTD | 10,000 | $301.0M | 0.01% | |
| 118 | NKTREURNEKTAR THERAPEUTICS | 6,057 | $296.0M | 0.01% | |
| 119 | AGLEUSDAEGLEA BIOTHERAPEUTICS INC | 25,694 | $272.0M | 0.01% | |
| 120 | VCELVERICEL CORP | 27,211 | $264.0M | 0.01% | |
| 121 | TGTXTG THERAPEUTICS INC | 100,000 | $258.0M | 0.01% | Put |
| 122 | —ACASTI PHARMA INC | 206,677 | $117.0M | 0.00% | |
| 123 | —ONCOSEC MED INC | 50,000 | $69.0M | 0.00% | |
| 124 | —ELLOX PHARMACEUTICALS INC | 2,961 | $50.0M | 0.00% | |
| 125 | —CAPRICOR THERAPEUTICS INC | 4,000 | $5.0M | 0.00% |
PreviousPage 2 of 2